REFERENCES
- Caprara C, Grimm C. From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res 2012;31:89–119
- Azuma M, Shearer TR. The role of calcium-activated protease calpain in experimental retinal pathology. Surv Ophthalmol 2008;53:150–163
- Sakamoto Y, Nakajima T, Fukiage C, Sakai O, Yoshida Y, Azuma M, et al. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina. Curr Eye Res 2000;21:571–580
- Oka T, Walkup RD, Tamada Y, Nakajima E, Tochigi A, Shearer TR, et al. Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl) amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. Neuroscience 2006;141:2139–2145
- Tamada Y, Fukiage C, Daibo S, Yoshida Y, Azuma M, Shearer TR. Involvement of calpain in hypoxia-induced damage in rat retina in vitro. Comp Biochem Physiol B Biochem Mol Biol 2002;131:221–225
- Nakajima E, David LL, Bystrom C, Shearer TR, Azuma M. Calpain-specific proteolysis in primate retina: contribution of calpains in cell death. Invest Ophthalmol Vis Sci 2006;47:5469–5475
- Nakajima E, Hammond KB, Rosales JL, Shearer TR, Azuma M. Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells. Invest Ophthalmol Vis Sci 2011;52:7059–7067
- Paquet-Durand F, Johnson L, Ekström P. Calpain activity in retinal degeneration. J Neurosci Res 2007;85:693–702. Review
- Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010;1802:80–91. Review
- Shirasaki Y, Yamaguchi M, Miyashita H. Retinal penetration of calpain inhibitors in rats after oral administration. J Ocul Pharmacol Ther 2006;22:417–424
- Moldoveanu T, Gehring K, Green DR. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 2008;20:404–408